Arkolith/Insider Trading/MAZE/Form 4

Dandekar Atul

CSBOMaze Therapeutics, Inc. (MAZE) · full profile →Form 4 · filed Apr 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$220K
Net Open-Market Flow
-$220K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 30, 2026Option exercise(M)8K$10.42$78K18K
Mar 30, 2026Sell(S)7K$29.26$196K11K
Mar 30, 2026Sell(S)790$30.02$24K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 30, 2026Option exercise(M)8K—$052K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002050167-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML